PALIFERMIN SIGNIFICANTLY REDUCES SEVERE ORAL MUCOSITIS IN SUBJECTS WITH RESECTED LOCALLY ADVANCED HEAD AND NECK CANCER UNDERGOING POST-OPERATIVE CONCURRENT RADIO-CHEMOTHERAPY

被引：0
|
作者：
Henke, M. [1 ]
Alfonsi, M. [2 ]
Foa, P. [3 ]
Giralt, J. [4 ]
Bardet, E. [5 ]
Cerezo, L. [6 ]
Salzwimmer, M. [7 ]
Whiley, M. [8 ]
Emmerson, L. [8 ]
Berger, D. [9 ]
机构：
[1] Univ Klinikum Freiburg, Dept Radiooncol, Freiburg, Germany
[2] Inst St Catherine, Serv Radiotherapie, Avignon, France
[3] San Paolo Univ Hosp, Dept Oncol, Milan, Italy
[4] Vall dHebron Univ Hosp, Dept Radiat Oncol, Barcelona, Spain
[5] CRLCC Nantes Atlantiques, Nantes, France
[6] Hosp Univ Princesa, Radiat Oncol, Madrid, Spain
[7] Ear Nose & Throat Univ Hosp Graz, Dept Gen ENT, Graz, Austria
[8] Amgen Ltd, Cambridge, England
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
460
引用
收藏
页码：S152 / S152
页数：1
相关论文
共 34 条
  • [21] Phase I/II study of concurrent erlotinib and chemoradiation for post-resected locally advanced squamous head and neck cancer (HNSCC):: A Gicor study
    de la Vega, F. Arias
    Herruzo, I.
    de las Heras, M.
    de la Torre, A.
    del Rio, L.
    Contreras, J.
    Prieto, I.
    Garcia Saenz, J. A.
    Amador, M. L.
    Calvo, F. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S428 - S428
  • [22] Phase I/II study of concurrent erlotinib and chemoradiation for post-resected locally advanced squamous head and neck cancer (HNSCC): A GICOR study
    Arias de la Vega, F.
    Herruzo, I.
    de las Heras, M.
    de la Torre, A.
    del Rio, L.
    Contreras, J.
    Prieto, I.
    Garcia, J. A.
    Amador, M. L.
    Calvo, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] Post-operative concurrent chemoradiation therapy using oral uracil-tegafur versus weekly intravenous fluorouracil for locally advanced rectal cancer
    Hsieh, Chen-Hsi
    Chen, Yu-Jen
    Chang, Kou-Hwa
    Hsu, Hsi-Hsien
    Liu, Chien-Kuo
    Hung, Shih-Kai
    Chen, Hong-Wen
    Lai, Yuen-Liang
    Hsu, Tzu-Chi
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3709 - 3715
  • [24] Randomized clinical trial on 7-days-a-week post-operative radiotherapy vs concurrent post-operative radiochemotherapy in locally advanced cancer of the oral cavity/oropharynx: a report on acute normal tissue reactions
    Suwinski, Rafal
    Wozniak, Grzegorz
    Misiolek, Maciej
    Jaworska, Magdalena
    Kozaczka, Maciej
    Bal, Wieslaw
    Nowara, Elzbieta
    Miszczyk, Leszek
    BRITISH JOURNAL OF RADIOLOGY, 2016, 89 (1061):
  • [25] Randomised clinical trial on 7-days-a-week postoperative radiotherapy vs. concurrent postoperative radio-chemotherapy in locally advanced cancer of the oral cavity/oropharynx
    Wozniak, Grzegorz
    Misiolek, Maciej
    Idasiak, Adam
    Debosz-Suwinska, Iwona
    Jaworska, Magdalena
    Bal, Wieslaw
    Maciejewski, Boguslaw
    Miszczyk, Leszek
    Skladowski, Krzysztof
    Suwinski, Rafal
    BRITISH JOURNAL OF RADIOLOGY, 2020, 93 (1116):
  • [26] Randomized Clinical Trial on 7-days-a-week Postoperative Radiotherapy vs. Concurrent Postoperative Radio-chemotherapy in Locally Advanced Cancer of the Oral Cavity/Oropharynx
    Wozniak, G.
    Misiolek, M.
    Idasiak, A.
    Debosz-Suwinska, I.
    Jaworska, M.
    Kozaczka, M.
    Bal, W.
    Maciejewski, B. A.
    Miszczyk, L.
    Suwinski, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S54 - S54
  • [27] The sensitivity, specificity and predictive values of PET-CT, MRI and neck US in the detection of residual neck disease after definitive radio-chemotherapy in locally-advanced head and neck cancer: preliminary report of a prospective study
    Marucci, L.
    Giovinazzo, G.
    Di Marzo, A.
    Manciocco, V.
    Pellini, R.
    Vidiri, A.
    Meduri, G.
    Spriano, G.
    Arcangeli, G.
    EJC SUPPLEMENTS, 2007, 5 (04): : 136 - 136
  • [28] Can "early" and "late" 18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?
    Castaldi, Paola
    Rufini, Vittoria
    Bussu, Francesco
    Micciche, Francesco
    Dinapoli, Nicola
    Autorino, Rosa
    Lago, Mariaelena
    De Corso, Eugenio
    Almadori, Giovanni
    Galli, Jacopo
    Paludetti, Gaetano
    Giordano, Alessandro
    Valentini, Vincenzo
    RADIOTHERAPY AND ONCOLOGY, 2012, 103 (01) : 63 - 68
  • [29] ROMAN: PHASE 3 TRIAL OF AVASOPASEM MANGANESE (GC4419) FOR SEVERE ORAL MUCOSITIS (SOM) IN PATIENTS RECEIVING CHEMORADIOTHERAPY (CRT) FOR LOCALLY ADVANCED HEAD AND NECK CANCER ( LAHNC)
    Cullen, Elizabeth
    Brown, Heather
    Carringer, Jessica
    Amado, Aida
    Pitre, Lacey
    Anderson, Carryn
    ONCOLOGY NURSING FORUM, 2023, 50 (02)
  • [30] A double-blind, randomized, placebo-controlled trial of I-glutamine for the severe oral mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer.
    Tsujimoto, Takae
    Yamamoto, Yoshifumi
    Wasa, Masafumi
    Takenaka, Yukinori
    Nakahara, Wataru
    Takagi, Tatsuya
    Tsugane, Mamiko
    Hayashi, Noriyuki
    Maeda, Kazuhisa
    Inohara, Hidenori
    Uejima, Etsuko
    Ito, Toshinori
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
1234